Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

This is a prospective study to determine if the use of curcumin randomized against placebo will reduce cancer progression in patients with prostate cancer undergoing active surveillance.

Trial Details

NCT ID
NCT03769766
Phase
PHASE3
Sponsor
University of Texas Southwestern Medical Center
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Curcumin
  • Placebo
Locations (sample)
  • Dallas, Texas, United States|32.78306,-96.80667

Key Eligibility Criteria

  • Age between 40-89 years
  • Biopsy proven, low-risk, localized prostate cancer (minimum of 8 cores)
  • May have had biopsy within last 12 months
  • ≤4 separate locations in the prostate involved with cancer. If multiple cores are obtained from same lesion or area than this will count as one loc…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →